AIT Austrian Institute of Technology GmbH:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:AIT Austrian Institute of Technology GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10317
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AIT Austrian Institute of Technology GmbH (AIT) is a research and technology organisation which provides research and development services. The institute provides research and technological development for infrastructure related technologies in the fields of energy, mobility systems, low-emission transport, health and bioresources, digital safety and security, automation and control, among others. Its health and environment research services include biomedical and bio molecular solutions, biological resources database, microbial detection and water treatment, among others. It offers services for the preparation of smart grids, photovoltaics, thermal energy systems, smart cities and develops business models in mobility, and digital safety and security. It operates in Vienna, Wiener Neustadt, Braunau am Inn, Graz, Tirol and Tulln, Austria. AIT is headquartered in Vienna, Austria.

AIT Austrian Institute of Technology GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH – Key Employees 17
AIT Austrian Institute of Technology GmbH – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
AIT Austrian Institute of Technology GmbH, Medical Equipment, Key Facts 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment Deals By Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Deals By Market, 2012 to YTD 2018 8
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Blue Earth Diagnostics and Seibersdorf Lab Enters into Distribution Agreement 10
Nanyang Technological University Enters into Research Agreement with Austrian Institute of Technology and Medical University of Vienna 11
Caprion Biosciences, Asuragen and AIT Austrian Institute of Technology Enter into Agreement with Cancer Research and Abcodia 12
AIT Austrian Institute Enters into Co-Development Agreement with BioVendor and Scienion 14
RiboMed Enters Into Development Agreement With Austrian Institute Of Technology For Lung Cancer Assay 15
Abcodia Partners with AIT Austrian Institute of Technology 16
AIT Austrian Institute of Technology GmbH, Key Employees 17
AIT Austrian Institute of Technology GmbH, Other Locations 19
AIT Austrian Institute of Technology GmbH, Subsidiaries 19

List of Figures
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
AIT Austrian Institute of Technology GmbH, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[AIT Austrian Institute of Technology GmbH:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Velesto Energy Bhd (UMWOG):企業の財務・戦略的SWOT分析
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, is an oilfield service provider. It serves customers in upstream sector of the oil and gas industry. The company owns and operates offshore drilling rigs and modular and versatile workover units. Its oilfield service offerings inc …
  • Tyme Technologies Inc (TYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Tyme Technologies Inc (Tyme) is a clinical-stage pharmaceutical company. The company focused on discovering and developing targeted cancer therapeutics for oncology indications. It develops clinical program SM-88, an oral tyrosine-based therapy that is currently in Phase II development for p …
  • CoImmune Inc (ARGS):企業の財務・戦略的SWOT分析
    Summary CoImmune Inc(CoImmune) formerly known as Argos Therapeutics Inc, is a biopharmaceutical company that develops and commercializes immunotherapies for the treatment of infectious diseases and cancer. The company develops a pipeline of products based on its proprietary Arcelis technology platfo …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SunTrust Banks Inc:企業の戦略・SWOT・財務情報
    SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report Summary SunTrust Banks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Venn Life Sciences Holdings Plc (VENN):企業の財務・戦略的SWOT分析
    Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology …
  • L Brands Inc:戦略・SWOT・企業財務分析
    L Brands Inc - Strategy, SWOT and Corporate Finance Report Summary L Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Eurobio Scientific SA (ALEHT):医療機器:M&Aディール及び事業提携情報
    Summary Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic i …
  • Vector Ltd (VCT):企業の財務・戦略的SWOT分析
    Vector Ltd (VCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析
    Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment o …
  • Personal Genome Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Emsland Group:企業の戦略・SWOT・財務情報
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Immunicum AB (IMMU)-製薬・医療分野:企業M&A・提携分析
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that develops immuno-oncology therapies for the treatment of solid tumors. The company’s products include COMBIG, CD70, SUBCUVAX and adenovirusvector. Its SUBCUVAX is in preclinical trials in combination with the adenovirus vector for t …
  • Tokuyama Corporation (4043):企業の財務・戦略的SWOT分析
    Tokuyama Corporation (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Hotel Royal Limited:戦略・SWOT・企業財務分析
    Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report Summary Hotel Royal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pear Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆